Skip to Main Content

Paper Details

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.
ESMO Open
16
2020
Author NameAffiliation
Patrick Y WenDana Farber Cancer Institute
Jordi RodonHospital Vall d'Hebron
Warren P MasonPrincess Margaret Hospital Cancer Centre
John F de GrootUniversity of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2